270.37
Iqvia Holdings Inc stock is traded at $270.37, with a volume of 1.09M.
It is down -1.69% in the last 24 hours and up +4.22% over the past month.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
See More
Previous Close:
$275.02
Open:
$274.9
24h Volume:
1.09M
Relative Volume:
0.76
Market Cap:
$44.50B
Revenue:
$16.63B
Net Income/Loss:
$1.39B
P/E Ratio:
33.51
EPS:
8.0674
Net Cash Flow:
$2.12B
1W Performance:
+1.48%
1M Performance:
+4.22%
6M Performance:
+63.23%
1Y Performance:
+53.02%
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IQV
Iqvia Holdings Inc
|
270.37 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
TMO
Thermo Fisher Scientific Inc
|
675.00 | 249.58B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
224.49 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
412.56 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
A
Agilent Technologies Inc
|
172.79 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-09-26 | Upgrade | TD Cowen | Hold → Buy |
| Mar-06-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-03-26 | Initiated | RBC Capital Mkts | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Nov-03-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-29-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-09-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
AI in Clinical Trials Market Set for Transformative Growth Through 2040, Unlocking Opportunities Across Trial Phases, Therapeutic Areas, End Users and Key Global Regions - GlobeNewswire Inc.
IQVIA Holdings stock heads into the open after closing at USD 268.05 - AD HOC NEWS
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
IQVIA Holdings stock reports 8.7 percent revenue growth - AD HOC NEWS
IQVIA Holdings stock heads into the open after a 0.8 percent gain - AD HOC NEWS
IQVIA Holdings (IQV) Completes $2 Billion Senior Notes Offering to Refinance Debt - gurufocus.com
Iqvia completes $2 billion senior notes offering due 2034 - Investing.com
Form 8K IQVIA Holdings Inc For: 23 September By Investing.com - Investing.com India
IQVIA Raises $2.0 Billion in 6.375% Senior Notes Due 2034 to Refinance Debt - TradingView
IQVIA Holdings stock closes at USD 271.10 near its yearly high - AD HOC NEWS
IQVIA (NYSE:IQV) Nears Breakout With 10/10 Technical Strength and 9/10 Setup - ChartMill
iqvia holdings inc. Earnings dates - RTTNews
IQVIA Holdings stock heads into the open after reaching USD 271.10 - AD HOC NEWS
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - fortune.com
IQVIA Holdings stock heads into the open after a 1.12 percent drop - AD HOC NEWS
IQVIA Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
IQVIA Holdings stock edges lower as analysts lift price targets - AD HOC NEWS
IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring Growth Potential With A 4.33% Upside - DirectorsTalk Interviews
IQVIA Holdings stock heads into the open after a 1.0 percent dip - AD HOC NEWS
IQVIA Holdings Inc. (IQV) Stock Price, News, Quote & History - Yahoo! Finance Canada
IQVIA Holdings (IQV) Prices $2b Notes, Does The Stock Look Fairly Valued? - Yahoo Finance
IQVIA (IQV) Stock Could Be Undervalued After Its 42% Run - Yahoo Finance
Iqvia Holdings Stock Price Forecast. Should You Buy IQV? - StockInvest.us
IQVIA Holdings Inc. (IQV) Key Financial Ratios – Valuation, Profitability & More - Value Research
IQV: IQVIA Holdings Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
IQVIA Holdings Inc (IQV): GF Score of 92 Signals Strong Outperfo - GuruFocus
IQVIA Stock Rises 60% in 6 Months: Here's What You Should Know - TradingView
IQVIA Holdings stock hits 52-week high at 271.82 USD By Investing.com - Investing.com Nigeria
IQVIA Holdings stock hits 52-week high at 271.82 USD - Investing.com
A Strong Rebound Case of IQVIA Holdings (IQV) - Yahoo Finance
The Trade Desk, Inc. Expands Integrations with Veeva Systems Inc. and Iqvia Holdings Inc. for Healthcare Measurement and Optimization for Pharma Advertisers - marketscreener.com
IQVIA Holdings stock gains support as $2 billion notes offering underpins balance sheet - ad-hoc-news.de
IQVIA Holdings Announces $2 Billion Senior Notes Offering - The Globe and Mail
IQVIA (NYSE: IQV) Announces $2 Billion Senior Notes Offering to Refinance Existing Debt - Kalkine Media
IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector? - Yahoo Finance
IQVIA Holdings stock dips as USD 2 billion notes add to debt debate - ad-hoc-news.de
Form 8K IQVIA Holdings Inc For: 10 September By Investing.com - Investing.com Canada
IQVIA Holdings stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
IQVIA Announces Pricing of Senior NotesSeptember 9, 2026 - biospace.com
IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus
IQVIA stock rises amid $2 billion senior notes offering By Investing.com - Investing.com South Africa
IQVIA Subsidiary Prices $2 Billion of 2034 Senior Notes - marketscreener.com
IQVIA prices $2.0B of 2034 senior notes at 6.375% to refinance 2026 debt - TradingView
IQVIA (NYSE: IQV) plans $2B notes sale to redeem 2026 bonds and reduce credit-line debt - Stock Titan
IQVIA Holdings Inc. Announces Pricing of $2,000,000,000 Senior Notes Due 2034 - marketscreener.com
IQVIA Announces Offering of Senior Notes - iqvia.com
IQVIA Holdings stock falls as new USD 2 billion notes offering tightens funding profile - ad-hoc-news.de
IQV Stock Quote Price and Forecast - CNN
Is IQVIA Holdings (NYSE:IQV) Ready for More Attention? - Kalkine Media
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):